Compare Oscar Health Inc (OSCR) vs Seagate Technology Holdings PLC (STX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Seagate Technology Holdings PLC — how do they compare? Oscar Health Inc trades at $33.37 (market cap $10.22B), while Seagate Technology Holdings PLC trades at $783 (market cap $176.19B). The key difference: Seagate Technology Holdings PLC is far larger — about 17.2× Oscar Health Inc's market cap, and Seagate Technology Holdings PLC pays a 0.38% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Seagate Technology Holdings PLC for 41 Days on average.
| OSCR | STX | |
|---|---|---|
Market Cap | $10.22B | $176.19B |
Volume | 4,123,394 | 5,061,875 |
Sector | Health | Technology |
52-Week High | $33.81 | $1.09K |
52-Week Low | $10.85 | $211.63 |
Typical Hold Time | 15 Days | 41 Days |
Enterprise Value | $6.57B | $178.34B |
Dividend Yield | — | 0.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Seagate Technology (STX) trades at $774.83, down 4.03% amid concerns about increased competition from Toshiba's planned hard drive production expansion. The stock shows strong fundamental performance with Q2 2026 EPS of $5.71 beating expectations by 12%, and robust profitability metrics including 26.11% net income margin and 371.53% ROE. Technical indicators signal bearish momentum with price below key pivot points, though RSI suggests potential oversold conditions. Analyst consensus remains positive with 54% buy ratings and $1,130 price target representing 46% upside potential.
STX presents a compelling growth story driven by AI storage demand, but faces near-term headwinds from competitive threats. The company's strong earnings beat streak and projected 2026 revenue growth to $12.2B support long-term optimism, while current valuation multiples appear elevated. Key risks include pricing pressure from new capacity and dependency on AI infrastructure spending cycles.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Seagate Technology Holdings PLC
Seagate is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital
Read more on STX →
